Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof

Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof

US Patent 11377494 · Granted Jul 5, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies2025
Monoclonal antibodies against IgV domain of B7-H3 and uses thereof2025
Antibodies to human B7x for treatment of metastatic cancer2025
Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formul2024
Monoclonal antibodies against human tim-32024
HHLA2 as a novel inhibitor of human immune system and uses thereof2022
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for 2021
B7X and its derivatives for treating and preventing cardiovascular disease2020
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for 2019
HHLA2 as a novel inhibitor of human immune system and uses thereof2018
Antibodies to human B7x for treatment of metastatic cancer2016